Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes. (October 2016)
- Record Type:
- Journal Article
- Title:
- Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes. (October 2016)
- Main Title:
- Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes
- Authors:
- Monteiro da Rocha, Andre
Guerrero-Serna, Guadalupe
Helms, Adam
Luzod, Carly
Mironov, Sergey
Russell, Mark
Jalife, José
Day, Sharlene M.
Smith, Gary D.
Herron, Todd J. - Abstract:
- Abstract: Aims: Mutations of cardiac sarcomere genes have been identified to cause HCM, but the molecular mechanisms that lead to cardiomyocyte hypertrophy and risk for sudden death are uncertain. The aim of this study was to examine HCM disease mechanisms at play during cardiac differentiation of human HCM specific pluripotent stem cells. Methods and results: We generated a human embryonic stem cell (hESC) line carrying a naturally occurring mutation of MYPBC3 ( c . 2905 + 1 G > A ) to study HCM pathogenesis during cardiac differentiation. HCM-specific hESC-derived cardiomyocytes (hESC-CMs) displayed hallmark aspects of HCM including sarcomere disarray, hypertrophy and impaired calcium impulse propagation. HCM hESC-CMs presented a transient haploinsufficiency of cMyBP-C during cardiomyocyte differentiation, but by day 30 post-differentiation cMyBP-C levels were similar to control hESC-CMs. Gene transfer of full-length MYBPC3 during differentiation prevented hypertrophy, sarcomere disarray and improved calcium impulse propagation in HCM hESC-CMs. Conclusion(s): These findings point to the critical role of MYBPC3 during sarcomere assembly in cardiac myocyte differentiation and suggest developmental influences of MYBPC3 truncating mutations on the mature hypertrophic phenotype. Highlights: A human stem-cell derived cardiomyocyte model of HCM is proposed. The model recapitulates hallmarks aspects of HCM in vitro. Hallmarks include sarcomere disarray, hypertrophy and impairedAbstract: Aims: Mutations of cardiac sarcomere genes have been identified to cause HCM, but the molecular mechanisms that lead to cardiomyocyte hypertrophy and risk for sudden death are uncertain. The aim of this study was to examine HCM disease mechanisms at play during cardiac differentiation of human HCM specific pluripotent stem cells. Methods and results: We generated a human embryonic stem cell (hESC) line carrying a naturally occurring mutation of MYPBC3 ( c . 2905 + 1 G > A ) to study HCM pathogenesis during cardiac differentiation. HCM-specific hESC-derived cardiomyocytes (hESC-CMs) displayed hallmark aspects of HCM including sarcomere disarray, hypertrophy and impaired calcium impulse propagation. HCM hESC-CMs presented a transient haploinsufficiency of cMyBP-C during cardiomyocyte differentiation, but by day 30 post-differentiation cMyBP-C levels were similar to control hESC-CMs. Gene transfer of full-length MYBPC3 during differentiation prevented hypertrophy, sarcomere disarray and improved calcium impulse propagation in HCM hESC-CMs. Conclusion(s): These findings point to the critical role of MYBPC3 during sarcomere assembly in cardiac myocyte differentiation and suggest developmental influences of MYBPC3 truncating mutations on the mature hypertrophic phenotype. Highlights: A human stem-cell derived cardiomyocyte model of HCM is proposed. The model recapitulates hallmarks aspects of HCM in vitro. Hallmarks include sarcomere disarray, hypertrophy and impaired calcium impulse propagation. HCM phenotype was associated to transient haploinsufficiency of cMyBPC during differentiation. Gene transfer of full-length MYBPC3 during differentiation prevented HCM phenotype. … (more)
- Is Part Of:
- Journal of molecular and cellular cardiology. Volume 99(2016:Oct.)
- Journal:
- Journal of molecular and cellular cardiology
- Issue:
- Volume 99(2016:Oct.)
- Issue Display:
- Volume 99 (2016)
- Year:
- 2016
- Volume:
- 99
- Issue Sort Value:
- 2016-0099-0000-0000
- Page Start:
- 197
- Page End:
- 206
- Publication Date:
- 2016-10
- Subjects:
- Cardiomyopathy -- Hypertrophy -- Stem cells -- Cardiac differentiation -- Optical mapping -- Stem cell derived cardiomyocytes
Cardiology -- Periodicals
Heart Diseases -- Periodicals
Molecular Biology -- Periodicals
Cardiologie -- Périodiques
Cardiology
Electronic journals
Periodicals
616.12 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00222828 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00222828 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/00222828 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.yjmcc.2016.09.004 ↗
- Languages:
- English
- ISSNs:
- 0022-2828
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5020.690000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7754.xml